The bill amends section 1509 of the Public Health Service Act to reauthorize and expand the WISEWOMAN program by allowing the Centers for Disease Control and Prevention to award supplemental grants to existing grant recipients. Those grants fund additional preventive services — explicitly blood‑pressure and cholesterol screening, health education, referrals for medical treatment, follow‑up to the extent practicable, and program evaluation.
Eligibility is broadened to include not only women served under existing section 1501 grants (the NBCCEDP breast and cervical cancer screening grantees) but also other low‑income women as the Secretary specifies. The bill authorizes $250 million in appropriations for fiscal years 2027 through 2031 to support these activities.
At a Glance
What It Does
The bill permits the CDC director to award supplemental grants to section 1501 grantees to add blood‑pressure and cholesterol screenings, health education, referral and follow‑up services, and evaluation. It also allows grantees to designate other providers, subject to Secretary approval.
Who It Affects
Primary affected parties are existing WISEWOMAN/NBCCEDP grantees, state and local health departments, community health centers and any entities designated by grantees, and low‑income women who will be eligible for expanded cardiovascular screening and education.
Why It Matters
This creates an explicit federal funding stream and statutory authority to integrate cardiovascular prevention services into programs that serve low‑income women, potentially shifting early detection and referral patterns and generating program data for public‑health planning.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a standalone section to authorize supplemental grants through the CDC to expand preventive cardiovascular services delivered by organizations already funded under section 1501 (the breast and cervical cancer screening grants). Those supplemental grants are intended to support on‑the‑ground activities: measuring blood pressure and cholesterol, delivering targeted health education about cardiovascular risk, making referrals for medical care when screening finds elevated risk, and conducting surveillance or program monitoring to evaluate impact.
Eligibility is intentionally broader than the current WISEWOMAN footprint: it covers women already served through section 1501 grants and allows the Secretary to set eligibility criteria for ‘‘other women who are low‑income.’' That gives the agency room to align eligibility with income thresholds, local program capacity, or other state policies rather than locking in a single national definition.The bill sets provider rules that favor integrating these services into existing breast and cervical cancer screening sites but also permits grant recipients to designate outside entities — for example, community health centers or mobile clinics — if the Secretary approves the designations. That approval step centralizes quality control but adds an administrative checkpoint for grantees.Finally, the statute specifies the dollar figure and multi‑year window for appropriations: $250 million total for fiscal years 2027 through 2031.
The funding authorization establishes the program’s finance ceiling but leaves allocation, award criteria, per‑grantee award sizes, and evaluation metrics to CDC rulemaking or guidance.
The Five Things You Need to Know
The bill expressly authorizes the CDC Director to award supplemental grants to section 1501 (NBCCEDP) grantees to add cardiovascular preventive services.
Screenings explicitly named are blood‑pressure and cholesterol checks, plus health education; referral and follow‑up services are required 'to the extent practicable.', Eligibility for services includes both women already receiving section 1501 services and 'other women who are low‑income' as defined by the Secretary.
Grantees may provide services directly through their existing breast/cervical screening entities or designate other entities, but designated providers require Secretary approval.
Congress authorizes $250,000,000 in appropriations to cover these supplemental grants for fiscal years 2027 through 2031.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Authority for supplemental screening and referral projects
This subsection gives the CDC Director explicit authority to award supplemental grants to existing section 1501 grantees to deliver preventive health services beyond breast and cervical screening. Practically, it creates a mechanism to fund blood‑pressure and cholesterol screening, health education, referrals for medical treatment, and program evaluation. The provision ties the scope of allowable activities to grants, not a separate entitlement, meaning implementation will depend on competitive or formula awards and CDC’s program guidance.
Eligibility—who can receive services
This subsection defines eligible beneficiaries to include women already served under section 1501 grants and 'other women who are low‑income' as determined by the Secretary. The Secretary’s discretion to set eligibility criteria allows tailoring to local poverty measures or program capacity but also creates potential variability across jurisdictions in who actually gets screened and educated.
Authorized providers and designation process
Services may be delivered by entities that already screen for breast and cervical cancer under section 1501 or by other entities designated by the grant recipient, subject to Secretary approval. This design allows grantees to partner with community clinics, mobile units, or other providers to expand reach, while giving CDC oversight to vet designated providers and maintain program standards.
Funding authorization and timeframe
This subsection authorizes $250 million for fiscal years 2027–2031 to carry out the section. The authorization sets a statutory funding ceiling but does not specify award formulas, per‑award amounts, or administrative expenses, leaving critical allocation decisions to CDC and appropriators.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Low‑income women at risk for cardiovascular disease — They gain access to blood‑pressure and cholesterol screening, health education, and referrals through existing public‑health channels, potentially improving early detection and linkage to care.
- State and local health departments and NBCCEDP grantees — The authorization provides a new, statutory pathway to fund integrated preventive services and expand population health activities through familiar program infrastructure.
- Community health centers and designated partner providers — Organizations approved as designated providers can receive grant‑supported work expanding their preventive‑care role and outreach to underserved women.
- Public‑health researchers and program evaluators — The explicit requirement for surveillance or program monitoring creates opportunities for stronger data collection on women’s cardiovascular screening outcomes.
Who Bears the Cost
- Federal budget/appropriators — The bill authorizes $250 million over five fiscal years; realizing this spending depends on annual appropriations decisions and competing priorities.
- Grant recipients and local providers — Implementing screenings, follow‑up, and reporting will require staffing, training, and logistics; grantees may need to reallocate resources or secure matching funds.
- CDC administration — The agency must design award criteria, approve designated providers, oversee evaluations, and manage program integrity without specified additional administrative funding.
- State Medicaid programs and downstream healthcare providers — Referrals generated by screenings may increase demand for diagnostic tests and treatment, shifting costs to payers and clinical providers unless other funding covers follow‑up care.
Key Issues
The Core Tension
The bill balances expanding preventive cardiovascular services for low‑income women through an existing, trusted delivery network against leaving key details — beneficiary definitions, provider approval, funding distribution, and the extent of guaranteed follow‑up care — to agency discretion and appropriations, creating a trade‑off between flexibility and equitable, reliable access.
The statute creates a targeted funding stream and flexible eligibility rules, but it leaves many operational decisions to CDC and appropriators. The Secretary’s discretion to define 'low‑income' beneficiaries and to approve designated providers allows necessary tailoring to local conditions, yet it risks uneven access across states and grantees.
The phrase 'to the extent practicable' for follow‑up services is deliberately loose; it signals an intent to support linkage to care while avoiding a federal mandate to pay for downstream treatment, which could limit the program’s ability to ensure completed care pathways for women with identified risks.
The authorized $250 million covers a five‑year span but the bill does not specify how the money should be split across years, nor does it set per‑grantee award limits, performance metrics, or data standards. That leaves allocation, eligibility thresholds, evaluation design, and administrative overhead to future CDC guidance and annual appropriations — an implementation burden that could produce patchwork coverage or slow startup.
Finally, integrating cardiovascular screening into breast/cervical screening sites can be efficient but risks overtaxing staff and diverting resources from core cancer screening unless grant awards account for the full operational costs of the expansion.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.